A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life A randomized, double blind, comparative study of vitamin D3versus placebo in patients with Parkinson ...
A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life - RCT with vitamin D for Parkinson disease A randomized, double blind, comparative study of vitamin D3versus placebo in patients with Parkinson ...